“…In contrast, tumor suppressor lncRNAs with downregulated expression patterns in cancer include lincRNA-p21, Gas5, PTENP1, and lncRNA-LET (lncRNA low expression in tumor). For example, the high expression of HOTAIR with a pro-tumor effect has been implicated in various tumor types, including breast cancer [ 228 ], liver cancer [ 229 ], colorectal carcinoma [ 185 ], gastrointestinal stromal tumor [ 230 ], pancreatic cancer [ 231 ], non-small cell lung carcinoma (NSCLC) [ 232 ], nasopharyngeal carcinoma [ 233 ], laryngeal squamous cell carcinoma (LSCC) [ 234 ], esophageal squamous cell carcinoma (ESCC) [ 235 ], urothelial carcinoma [ 236 ], ovarian cancer [ 237 ], renal carcinoma [ 238 ], gall bladder cancer [ 239 ], nonfunctional pituitary adenoma [ 240 ], PCa [ 241 ], melanoma [ 242 ], and endometrial tumors [ 243 ].…”